New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 8, 2013
20:29 EDTALNYAlnylam presents pre-clinical results on ALN-CC5 at ASH
Alnylam Pharmaceuticals announced that it has presented new pre-clinical data with ALN-CC5, a subcutaneously administered RNAi therapeutic targeting complement component C5 for the treatment of complement-mediated diseases. These data were presented at the 55th Annual Meeting of the American Society of Hematology, ASH, held December 7 – 10, in New Orleans, and demonstrate that subcutaneous administration of ALN-CC5 in non-human primates, NHPs, led to an up to 98% knockdown of serum C5 and an up to 94% inhibition of hemolytic activity. Alnylam believes that ALN-CC5 – part of the company’s “Alnylam 5x15” product strategy – represents a novel approach for the treatment of complement-mediated diseases, with a potentially competitive profile compared with intravenously administered anti-C5 monoclonal antibody therapy. In addition, Alnylam presented two separate posters with new pre-clinical data on ALN-TMP, an RNAi therapeutic targeting TMPRSS6 for the treatment of beta-thalassemia and iron-overload disorders.
News For ALNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
07:31 EDTALNYArrowhead acquires Novartis' RNAi research and development portfolio
Subscribe for More Information
March 4, 2015
10:01 EDTALNYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:10 EDTALNYCowen to hold a conference
35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 4 at 8 am; not all company presentations may be webcasted. Webcast Link
05:37 EDTALNYAlnylam initiated with an Overweight at Barclays
Subscribe for More Information
February 27, 2015
09:58 EDTALNYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:59 EDTALNYAlnylam initiated with an Outperform at Cowen
Subscribe for More Information
February 23, 2015
07:22 EDTALNYSunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use